Navigation Links
Benchmark Research Honored With Industry Accolades
Date:4/26/2013

Austin, Texas (PRWEB) April 26, 2013

Benchmark Research is honored to be recognized by two industry leading professional organizations, the Association of Clinical Research Professionals (ACRP) and the World Vaccine Congress (WVC), at their annual conferences last week.

ACRP awarded the 2013 Outstanding Leadership in Clinical Research Award for Leadership as a CRC to Benchmark’s Ann Rutledge, MA, CCRC, during their annual Global Conference & Exhibition in Orlando, Fla. on April 14. The award recognizes individuals who have made exceptional leadership/practice contributions that have furthered the vision and mission of ACRP.

Based at Benchmark’s Austin clinical research site, Ann is both Manager of Quality Control and a Senior Clinical Research Coordinator. She is recognized for her extensive experience developing and implementing site processes and standard operating procedures, as well as for creating and presenting training internally and for ACRP. “Being acknowledged for a focus on continuous quality improvement is very rewarding,” said Ann, who has more than 16 years of experience in clinical research and 26 years in the medical field. A Certified CRC since 2002, Ann was the founding chapter chair for the ACRP Central Texas Chapter.

The WVC recognized Benchmark’s Fort Worth site, part of VaxNet/Vax Consortium, as “Highly Recommended” and runner-up in the Best Clinical Site & Trial Network category at the Sixth Annual Vaccine Industry Excellence (ViE) Awards presented on April 17 in Washington, D.C. The only awards ceremony dedicated to the vaccine industry, the ViE Awards honor individuals, organizations and initiatives which have made significant contributions over the past 12 months.

Last year Benchmark’s Austin site took home the 2012 ViE award in the Best Clinical Trial Site category, while VaxNet was Highly Recommended and runner-up for the then-separate Best Site Network category. “We are honored to be recognized again for our commitment to excellence in vaccine research,” said Mark Lacy, founder and CEO of Benchmark Research. “Both the ACRP award to Ann and the ViE awards to our sites underscore the priority Benchmark places on raising the standard in clinical research.”

Read the full story at http://www.prweb.com/releases/2013/4/prweb10667632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
2. PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs
3. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
4. iLab Solutions Conducts Its Third Annual Core Facility Benchmarking Study
5. SPIE Smart Structures/NDE Researchers Look to Nature for Inspiration
6. South Dakota School of Mines & Technology Researchers Document Splitting Water Molecules in Multiple Thermochemical Cycles with Goal to Sustain Hydrogen Energy
7. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
8. Crystal Research Associates, LLC Issues Quarterly Update on MetaStat, Inc.
9. Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
10. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
11. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
Breaking Biology News(10 mins):